Endocrinology (all articles)
[Abstract Only] Randomized trial tests metformin in women with type 2 diabetes in pregnancy
28 Sep, 2020 | 01:30h | UTCCommentary: Welcome news for pregnant women with type 2 diabetes – MedicalXpress
Commentary on Twitter
https://twitter.com/TIME_research/status/1306856108338933765
Randomized trial: Dapagliflozin in patients with chronic kidney disease
25 Sep, 2020 | 02:34h | UTCDapagliflozin in Patients with Chronic Kidney Disease – New England Journal of Medicine (free for a limited period)
Commentary: Dapagliflozin Cuts Renal Risks in Patients with CKD, Regardless of Diabetes Status – NEJM Journal Watch
Meta-analysis: Central fatness and risk of all-cause mortality
24 Sep, 2020 | 09:19h | UTC
Commentary on Twitter
https://twitter.com/bmj_latest/status/1308909015867494400
USPSTF draft statement: Insufficient evidence to screen for Vitamin D deficiency in asymptomatic adults
23 Sep, 2020 | 14:36h | UTC
Guideline: Management of dyslipidemia for cardiovascular disease risk reduction
22 Sep, 2020 | 09:33h | UTCSummary: VA/DoD Guidelines on Dyslipidemia Recommend Against Frequent LDL Testing – NEJM Journal Watch
Commentary on Twitter
https://twitter.com/ATallantMD/status/1308199038513278978
Clinical update: Hormonal contraception in women with hypertension
22 Sep, 2020 | 09:32h | UTCHormonal Contraception in Women With Hypertension – JAMA (free for a limited period)
Commentary on Twitter
https://twitter.com/JAMA_current/status/1308088618846691330
Lifelong aspirin for all in the secondary prevention of chronic coronary syndrome: Still sacrosanct or is reappraisal warranted?
17 Sep, 2020 | 09:19h | UTCLifelong Aspirin for All in the Secondary Prevention of Chronic Coronary Syndrome: Still Sacrosanct or is Reappraisal Warranted? – Circulation (free for a limited period)
Multisystem effects of COVID-19: A concise review for practitioners
16 Sep, 2020 | 09:14h | UTCMultisystem effects of COVID-19: A concise review for practitioners – Postgraduate Medicine
Why COVID-19 is more deadly in people with obesity—even if they’re young
10 Sep, 2020 | 09:47h | UTCWhy COVID-19 is more deadly in people with obesity—even if they’re young – Science
How good a diet is intermittent fasting?
10 Sep, 2020 | 09:30h | UTCHow Good a Diet Is Intermittent Fasting? – Scientific American
WHO: More than 3 billion people protected from harmful trans-fat in their food
10 Sep, 2020 | 09:25h | UTCReport: Countdown to 2023: WHO report on global trans-fat elimination 2020 – World Health Organization
Commentary on Twitter
More than 3⃣ billion people across 5⃣8⃣ countries are now protected from harmful trans-fat in their food since the launch of WHO’s global #REPLACEtransfat initiative.
More details 👉https://t.co/3E5NIo8Y9Z #BeatNCDs pic.twitter.com/OHevkpBgaj
— World Health Organization (WHO) (@WHO) September 9, 2020
Podcast: Update on bariatric surgery—2020
9 Sep, 2020 | 09:18h | UTCAudio Clinical Review: Update on Bariatric Surgery—2020 – JAMA
Systematic review: Reduction in saturated fat intake for cardiovascular disease
8 Sep, 2020 | 01:07h | UTCReduction in saturated fat intake for cardiovascular disease – Cochrane Library
Summary: Effect of cutting down on the saturated fat we eat on our risk of heart disease – Cochrane Library
[Abstract Only] Meta-analysis: Effect of alternate-day fasting on obesity and cardiometabolic risk
6 Sep, 2020 | 21:24h | UTCSource: EvidenceAlerts
Case report: Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection
4 Sep, 2020 | 02:10h | UTCCommentary: Can COVID-19 cause diabetes? – MedicalXpress
Commentary on Twitter
https://twitter.com/nresearchnews/status/1301179637704331265
ADA Guideline synopsis: Pharmacologic approaches to glycemic treatment of Type 2 Diabetes
2 Sep, 2020 | 09:41h | UTC
#ESCCongress – [Abstract Only] Randomized trial: Cardiovascular and renal outcomes with Empagliflozin in heart failure
31 Aug, 2020 | 01:38h | UTCCommentaries: EMPEROR-Reduced: Empagliflozin Cuts Hospitalizations, CV Mortality in HFrEF – TCTMD AND EMPEROR-Reduced meets primary endpoint in heart failure with reduced ejection fraction – European Society of Cardiology AND Empagliflozin Outcome Trial in Patients With Chronic Heart Failure and a Reduced Ejection Fraction – EMPEROR-Reduced – American College of Cardiology
Related study: Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction – New England Journal of Medicine
Commentary on Twitter
Original Article: Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure (EMPEROR-Reduced Trial) #ESCCongress
— NEJM (@NEJM) August 29, 2020
#ESCCongress – [Abstract Only] SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
31 Aug, 2020 | 01:36h | UTC
Individuals with obesity and COVID‐19: A global perspective on the epidemiology and biological relationships
27 Aug, 2020 | 09:57h | UTCCommentaries: Obesity increases risk of complications from Covid-19, damages vaccine efficacy, study finds – CNN AND Obesity increases risk of Covid-19 death by 48%, study finds – The Guardian AND Obesity linked with higher risk for COVID-19 complications – University of North Carolina at Chapel Hill
[Abstract Only] Randomized trial: Closed-loop control in children with type 1 diabetes
27 Aug, 2020 | 09:45h | UTCCommentary: Artificial pancreas effectively controls type 1 diabetes in children age 6 and up – NIH News Releases
Effects of diet versus gastric bypass on metabolic function in diabetes
21 Aug, 2020 | 02:22h | UTCCommentaries: ‘Nearly identical’ metabolic benefits with surgery vs diet in people with type 2 diabetes – medwireNews AND Benefit of Gastric Bypass? It’s the Weight Loss – Physician’s Weekly
New-onset type 1 diabetes in children during COVID-19 pandemic
19 Aug, 2020 | 09:38h | UTCCommentaries: COVID-19 linked to increase in type 1 diabetes in children – Imperial College London AND Expert reaction to study linking COVID-19 to increase in type 1 diabetes in children – Science Media Centre
Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England
16 Aug, 2020 | 22:26h | UTC
Commentary on Twitter
NEW Research Article: Associations of type 1 and type 2 #Diabetes with #COVID19 -related #mortality in #England: a whole-population studyhttps://t.co/XVlq6UBszR
— The Lancet Diabetes & Endocrinology (@TheLancetEndo) August 14, 2020
Meta-analysis: The impact of obesity on severe disease and mortality in people with SARS‐CoV‐2
16 Aug, 2020 | 22:20h | UTC
Obesity and mortality among patients diagnosed with COVID-19
16 Aug, 2020 | 22:16h | UTCEditorial: COVID-19 and Severe Obesity: A Big Problem?
Summary for Patients: Obesity and Risk for Adverse Outcomes Among Patients Diagnosed With COVID-19
Commentary: Obesity Raises the Risk of Death From Covid-19 Among Men – The New York Times